Merck takes a back seat on CAR-T, handing assets to IntrexonMerck KGaA wants to get bigger in immuno-oncology, but from now on it won’t be taking a direct Share XMerck takes a back seat on CAR-T, handing assets to Intrexonhttps://pharmaphorum.com/news/merck-takes-a-back-seat-on-car-t-handing-assets-to-intrexon/
